ScholarIQanswers from OpenAlex

Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway

PaperCitations, authors & open-access status

Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway have?

ScholarIQcitation count

Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway has 117 citations in the OpenAlex counts ScholarIQ stores.

When was Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway published?

ScholarIQyear

Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway has 2018 year in the ScholarIQ index.

What is the open-access status of Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway?

ScholarIQoa status

Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway has hybrid oa status in the ScholarIQ index.

What is the DOI of Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway?

ScholarIQdoi

The DOI for Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway is on the source record.

What is the PMID of Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway?

ScholarIQpmid

The PMID for Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway is on the source record.

What is the OpenAlex record for Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway?

ScholarIQopenalex

The OpenAlex for Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial